医学
代谢综合征
免疫抑制
肝移植
重症监护医学
亚临床感染
短肠综合征
梅德林
多学科方法
移植
风险因素
风险评估
多学科团队
儿科
器官移植
内科学
作者
Maarten Buytaert,Eline Braekman,Kaat Van Overbeke,Agnieszka Prytula-Ebels,Pauline De Bruyne,Kathleen De Waele,Kristof Vandekerckhove,Sander Lefere,Ruth De Bruyne
摘要
Over the last decades, long-term survival after pediatric liver transplantation has improved substantially, highlighting the importance of long-term graft and recipient outcomes. About one in five pediatric liver transplant recipients will develop post-transplant metabolic syndrome (PTMS), a combination of cardiovascular risk factors increasing morbidity and mortality. In contrast to the classical metabolic syndrome (MetS), it is not always characterized by (abdominal) obesity. There are several contributing factors, among which sustained exposure to immunosuppression is a major contributor. As subclinical target organ damage is already present in childhood, cardiometabolic risk factors must be actively sought for and a structured approach including nephrological, endocrinological, and cardiological assessment is necessary. This work provides an overview of the existing literature on screening and management of post-transplant metabolic syndrome and its components. Despite consensus guidelines lacking, a patient-centered, multidisciplinary approach from the transplant team to the primary care providers is crucial to enhance long-term, meaningful survival of pediatric liver transplant recipients.
科研通智能强力驱动
Strongly Powered by AbleSci AI